DOCSLIB.ORG

Intracarotid Etomidate Is a Safe Alternative to Sodium Amobarbital for the Wada Test

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Intracarotid Etomidate Is a Safe Alternative to Sodium Amobarbital for the Wada Test CLINICAL REPORT Intracarotid Etomidate is a Safe Alternative to Sodium Amobarbital for the Wada Test Ramamani Mariappan, MD,* Pirjo Manninen, MD, FRCPC,* Mary P. McAndrews, PhD,w Melanie Cohn, PhD,w Peter Tai, MD, FRCPC, Taufik Valiante, MD, PhD, FRCS(C),y and Lashmi Venkatraghavan,z MD, FRCA, FRCPC* Conclusion: From our experience, etomidate is a safe alternative Background: The Wada procedure (the intracarotid amobarbital to sodium amobarbital for the Wada test for determining the procedure) has been used widely to evaluate the hemispheric hemispheric dominance for speech and in predicting the memory dominance of language and memory before temporal lobe sur- outcome. gery in patients with medically refractory seizures. Because of repeated shortage of sodium amobarbital, attempts have been Key Words: Wada test, sodium amobarbital, intracarotid eto- made to find a suitable alternative to sodium amobarbital. The midate injection, EEG and motor effects, language and speech aim of our study was to review our experience with the use of lateralization etomidate as an alternative to sodium amobarbital for Wada (J Neurosurg Anesthesiol 2013;00:000–000) testing in patients with medically refractory seizures. Methods: After the ethics approval, we retrospectively reviewed the charts of 29 consecutive patients who underwent Wada test he Wada procedure, also known as the intracarotid with etomidate. Data from a total of 50 hemispheric injections Tamobarbital procedure (IAP), has been used for >50 were reviewed and analyzed. This included the electro- years to evaluate language laterality and to predict the encephalographic and motor effects of etomidate injection and postoperative memory outcome in the surgical planning of their time course (onset and recovery), Wada test results (lan- patients with medically refractory temporal lobe epilepsy.1,2 guage laterality and memory performance), and all adverse The basic methodology of IAP is to inject a short-acting events during the procedure. intravenous (IV) anesthetic agent into the carotid artery to Results: Intracarotid administration of etomidate produced a anesthetize ipsilateral hemisphere, allowing one to assess the predictable electroencephalographic and motor effects in all language and memory functions of the contralateral hemi- sphere in isolation. Sodium amobarbital has been the patients. The desirable effect was seen with a single bolus dose of 1,2 2 mg followed by an infusion. Shivering was the most common standard drug used for IAP for >50 years. In most cen- side effect, seen in all the patients. Successful testing was possible ters, anesthesiologists were not usually present during this in nearly all patients without any major side effects. The “pass procedure and the radiologist usually injected the sodium rate” of valid tests was in good accord with our previous amobarbital. Because of frequent interruptions with the experience with the use of sodium amobarbital. supply and limited availability of sodium amobarbital, vari- ous anesthetic agents have been tried for this procedure, and hence, anesthesiologists are now being involved in this pro- cedure.3–9 The use of etomidate in IAP was developed by the Received for publication December 28, 2012; accepted April 11, 2013. Epilepsy Surgical Program at the Montreal Neurological From the Departments of *Anesthesia; wPsychology; Divisions of Institute, in which it was reported to be an effective alter- Neurology; and yNeurosurgery, Toronto Western Hospital, Uni- versityz Health Network, University of Toronto, Toronto, ON, native to sodium amobarbital, referring to the procedure as Canada. the etomidate speech and memory (eSAM) test.9 Intracarotid R.M.: helped with the analysis of the data, to write the manuscript, and administration of anesthetic agents poses unique pharmaco- approved the final manuscript; P.M.: helped to write the manuscript kinetic challenges for anesthesiologists. The purpose of this and approved the final manuscript; M.P.M.: helped to write the manuscript and approved the final manuscript; M.C.: helped with the study was to review our experience with the use of etomidate analysis of the data and approved the final manuscript; P.T.: helped as an alternative to sodium amobarbital for Wada testing in to write the manuscript and approved the final manuscript; T.V.: patients with medically refractory epilepsy. helped to write the manuscript and approved the final manuscript; L.V.: helped to conduct the study, analyze the data, write the manuscript, and approved the final manuscript. METHODS The authors have no funding or conflicts of interest to disclose. Reprints: Lashmi Venkatraghavan, MD, FRCA, FRCPC, Department Subjects of Anesthesia, Toronto Western Hospital, University Health Net- work, University of Toronto, 399 Bathurst Street, Toronto, ON, After the institutional research and ethics board Canada M5T 2S8 (e-mail: [email protected]). approval, we retrospectively reviewed the clinical, electro- Copyright r 2013 by Lippincott Williams & Wilkins encephalographic (EEG), and neuropsychological data of | J Neurosurg Anesthesiol Volume 00, Number 00, ’’ 2013 www.jnsa.com 1 Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. Mariappan et al J Neurosurg Anesthesiol Volume 00, Number 00, ’’ 2013 29 consecutive patients (one of whom underwent 2 proce- memory performance), and all complications during the dures) who underwent eSAM in our institution from Jan- procedure. Analysis of EEG changes included the time of uary 2007 to December 2011. All patients in our institution onset and recovery of slow wave activity in response to undergo extensive presurgical evaluation, consisting of etomidate infusion, the presence of sharp wave activity, noninvasive and invasive investigations (where required) and the contralateral spread of the slow wave activity. A before the surgical treatment for their medically refractory descriptive statistical analysis was performed using the epilepsy. Language dominance is usually determined by Statistical Package for the Social Sciences version 20. All functional magnetic resonance imaging (fMRI). Generally, values are expressed as mean ± SD. patients who are deemed to be at risk of drastic post- operative memory dysfunction are referred for IAP. RESULTS Procedure Atotalof29patientsunderwent50hemisphericin- jections. The demographic data are as shown in Table 1. All The procedures were performed in the neuro- patients received a 2-mg bolus of etomidate followed by the radiology suite. Patients were monitored with electro- infusion of 12 mg/h. The average duration of infusion was cardiography, noninvasive blood pressure monitoring, 3minutes26seconds(rangefrom2min46sto3min56s) and pulse oximetry. All patients had continuous mon- with a mean dose of 2.68 mg (dose range from 2.55 to itoring of 24-channel EEG. An anesthesiologist ad- 2.78 mg). Sixteen patients also had an injection of the ministered the drug and monitored the patient. A contralateral hemisphere (bilateral injection) to test the neuropsychologist performed the motor, language, and functional adequacy of the to-be-resected temporal lobe. In memory assessments during the procedure. 4patients,thetestwasrepeatedonthesamesidetoconfirm Under local anesthesia, the femoral artery was can- the validity of the first test because of initial poor contact nulated using a 5-F catheter with a dead space of 1.2 mL. with the patient, strong emotional reaction preventing full The catheter was advanced into the internal carotid artery engagement, failure of the preinjection items, and an un- until the tip of the catheter was at the level of the first usual delayed effect of etomidate. In patients who had bi- cervical (C1) vertebral body. A cerebral angiogram was lateral injections (n = 16), the average time between the first performed to confirm the absence of any significant cerebral and the second injections was 26 ± 7 minutes. cross-flow or abnormal vascularcirculation.Inallexcept1 case, the first injection was administered in the hemisphere EEG Effects After Etomidate Injection with the seizure focus to test the contralateral hemisphere, Immediately after the injection of etomidate, all thus mimicking surgery. Before the injection, patients were patients showed EEG slowing with delta and/or theta presented with 5 pictures of objects that they were to re- waves on the ipsilateral side. The onset of EEG slowing member. Etomidate 2 mg (2 mg/mL) was injected as a bolus was at 29.46 ± 12.69 seconds after the bolus, and the over 30 seconds using a syringe driver infusion pump recovery to baseline was 374.26 ± 170.19 seconds after (Medfusion 3500; Smith Medical MD Inc., St. Paul, stopping the infusion. Contralateral hemispheric EEG Minnesota) followed by an infusion of 6 mL/h (12 mg/h) slowing was also noticed in 9 patients. This slowing was etomidate. After the onset of contralateral hemiplegia, ad- observed mainly in the frontal areas (n = 9) and in some equate contact with the patient was verified by the execution patients (n = 5) in the parasagittal and temporal areas. of a simple verbal command or by observing the patient’s After the second injection, the onset of EEG effect was visually orienting or tracking stimuli. Then, all the memory earlier (24.2 ± 8.73 s) and the recovery was delayed items (10 common objects that were to be named) were (454.90 ± 184.39 s) compared with the first injection shown. The infusion was then stopped and from this point (Figs. 1, 2). This was not statistically significant. forward,
Load more

Recommended publications
  • Mapping Language Dominance Through the Lens of the Wada Test
    NEUROSURGICAL FOCUS Neurosurg Focus 47 (3):E5, 2019 Mapping language dominance through the lens of the Wada test Bornali Kundu, MD, PhD, John D. Rolston, MD, PhD, and Ramesh Grandhi, MD Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah The sodium amytal test, or Wada test, named after Juhn Wada, has remained a pillar of presurgical planning and is used to identify the laterality of the dominant language and memory areas in the brain. What is perhaps less well known is that the original intent of the test was to abort seizure activity from an affected hemisphere and also to protect that hemi- sphere from the effects of electroconvulsive treatment. Some 80 years after Paul Broca described the frontal operculum as an essential area of expressive language and well before the age of MRI, Wada used the test to determine language dominance. The test was later adopted to study hemispheric memory dominance but was met with less consistent suc- cess because of the vascular anatomy of the mesial temporal structures. With the advent of functional MRI, the use of the Wada test has narrowed to application in select patients. The concept of selectively inhibiting part of the brain to de- termine its function, however, remains crucial to understanding brain function. In this review, the authors discuss the rise and fall of the Wada test, an important historical example of the innovation of clinicians in neuroscience. https://thejns.org/doi/abs/10.3171/2019.6.FOCUS19346 KEYWORDS Wada test; language dominance; laterality; memory; epilepsy The removal of a tumor at the cost of the patient’s speech is mined by family history or could be “acquired” second- scarcely an accomplishment on which to congratulate oneself.
    [Show full text]
  • Regional Cerebral Perfusion and Amytal Distribution During the Wada Test
    Regional Cerebral Perfusion and Amytal Distribution During the Wada Test Rajith de Silva, Roderick Duncan, James Patterson, Ruth Gillham and Donald Hadley Departments of Neurology, Neuroradiology and Neuropsychology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, Scotland some studies have indicated that cerebral hypoperfusion The distribution of sodium amytal and its effect on regional induced by amytal does not usually involve the mesial cerebral perfusion during the intracarotid amytal (Wada) test temporal cortex (3). What then is the mode of action of the were investigated using high-resolution hexamethyl propyl- test? We have hypothesized that the test works either by eneamine oxime (HMPAO) SPECT coregistered with the pa tient's MRI dataset. Methods: Twenty patients underwent SPECT producing partial inactivation of mesial temporal structures or by inactivating mesial temporal structures indirectly (i.e., after intravenous HMPAO injection, and 5 patients had both intravenous and intracarotid injections in a double injection- by diaschisis). acquisition protocol. Results: All patients had hypoperfusion in To test these hypotheses, it is necessary to have clear and the territories of the anterior and middle cerebral arteries. Basal precise images of perfusion in the mesial temporal cortex. ganglia perfusion was preserved in 20 of 25 patients. Hypoperfu (Jeffery et al. [4] pointed out the difficulty of doing this with sion of the entire mesial temporal cortex was seen in 9 of 25 conventional slicing). It is also necessary to have measures patients. Partial hypoperfusion of the whole mesial cortex or both of the distribution of structures to which amytal is hypoperfusion of part of the mesial cortex was seen in 14 of 25 delivered and of the distribution of structures rendered patients.
    [Show full text]
  • Corpus Callosotomy E21 (1)
    CORPUS CALLOSOTOMY E21 (1) Corpus Callosotomy Last updated: September 9, 2021 HISTORY ......................................................................................................................................................... 1 EXTENT OF PROCEDURE ................................................................................................................................ 1 INDICATIONS .................................................................................................................................................. 2 PREOPERATIVE TESTS .................................................................................................................................... 2 PROCEDURE ................................................................................................................................................... 2 Anesthesia .............................................................................................................................................. 2 Position ................................................................................................................................................... 2 Incision & dissection .............................................................................................................................. 3 Callosotomy ........................................................................................................................................... 3 End of procedure ...................................................................................................................................
    [Show full text]
  • Non-Invasive Alternatives to the Wada Test in the Presurgical Evaluation of Language and Memory Functions in Epilepsy Patients
    Special article Epileptic Disord 2007; 9 (2): 111-26 Non-invasive alternatives to the Wada test in the presurgical evaluation of language and memory functions in epilepsy patients Isabelle Pelletier1,2, Hannelore C. Sauerwein1,2, Franco Lepore1,2, Dave Saint-Amour1,3, Maryse Lassonde1,2 1 Centre de recherche du Centre Hospitalier Universitaire Mère-Enfant (Sainte-Justine) 2 Centre de Recherche en Neuropsychologie et Cognition, Département de psychologie 3 Département d’ophtalmologie, Université de Montréal, Canada Received December 4, 2006; Accepted March 26, 2007 ABSTRACT – The cognitive outcome of the surgical removal of an epileptic focus depends on the assessment of the localisation and functional capacity of language and memory areas which need to be spared by the neurosurgeon. Traditionally, presurgical evaluation of epileptic patients has been achieved by means of the intracarotid amobarbital test assisted by neuropsychological measures. However, the advent of neuroimaging techniques has provided new ways of assessing these functions by means of non-invasive or minimally invasive methods, such as anatomical and functional magnetic resonance imaging, positron emission tomography, single-photon emission computed tomography, transcranial magnetic stimulation, functional transcranial Doppler monitoring, magnetoencephalography and near infrared spectroscopy. This paper aims at comparing and evaluating the traditional and recent preoperative approaches from a neuropsychological perspective. Key words: epilepsy surgery, neuroimaging technique, intracarotid amobarbital test, language, memory Surgery to remove epileptic brain tis- providing complete seizure control sue (i.e., lobectomy, lesionectomy, and improved quality of life. The out- hemispherectomy) is a widely used come of the surgery depends on accu- and effective treatment for patients rate localization and lateralization of Correspondence: suffering from intractable seizures the epileptogenic zone as well as on Maryse Lassonde (Gates and Dunn 1999).
    [Show full text]
  • Magnetoencephalography (MEG)
    Model Coverage Policy Magnetoencephalography (MEG) INTRODUCTION Magnetoencephalography (MEG), also known as seizures.1 Early resective epilepsy surgery has beneficial Magnetic Source Imaging (MSI) is the noninvasive effects on progressive and disabling consequences of measurement of the magnetic fields generated by brain uncontrolled seizures. Timely recognition and referral are vital activity. Typical MEG recordings are made within a to realization of the benefits of epilepsy resective surgery.2,3 magnetically shielded room using a device that has 100 Value of MEG in localization and resective surgery. to 300 magnetometers or gradiometers (sensors). They A cardinal principle in resective surgery is to remove only are arranged in a helmet-shaped container called a Dewar. the abnormal tissue and preserve normal functional tissue. The Dewar is filled with liquid helium needed to produce This is particularly crucial in the cortical regions of the brain. superconductivity. The brain sources producing the magnetic Normal and abnormal tissues are often in close proximity and field maps can be easily mapped and displayed on a co- may appear contiguous and indistinguishable to naked eye registered MRI. This results in a visual display of normal inspection. brain activity such as the location of eloquent cortex for vision, touch, movement, or language. It displays equally well Even when the abnormal structure, such as a vascular abnormal brain activity such as epileptic discharges. Such malformation, may be obvious, the location of a normal depictions are useful in pre-surgical brain mapping in patients eloquent brain tissue cannot be determined without with epilepsy, brain tumors, and vascular malformations. specialized testing. Eloquent areas are those subserving essential functions such as the sense of touch, vision Importance of epilepsy surgery.
    [Show full text]
  • SURGERY for SEIZURES Volve Only the Anterior Two Thirds of the Corpus Callo- Sum Unless the Patient Has Severe Retardation
    Vol. 334 No. 10 CURRENT CONCEPTS 647 REVIEW ARTICLE partial removal and partial disconnection of affected tissue; these and related techniques are designed to re- CURRENT CONCEPTS duce movement of the remaining portions of the brain within the cranial vault and to ensure resorption of cer- ebrospinal fluid. Corpuscallosotomies now usually in- SURGERY FOR SEIZURES volve only the anterior two thirds of the corpus callo- sum unless the patient has severe retardation. For some JEROME ENGEL, JR., M.D., PH.D. localized cortical resections, however, intraoperative test- ing may be necessary, which prolongs the operation and occasionally requires the patient to be briefly awakened F the approximately 2 million Americans with a from anesthesia. New techniques for treating epilep- O diagnosis of epilepsy who are treated with antiep- togenic regions within primary cortical areas, such as ileptic drugs, 20 percent continue to have seizures 1; this those controlling language and motor function, include group of patients accounts for over 75 percent of the the removal of a discrete lesion without disturbing the cost of epilepsy in the United States. 2 For many of those adjacent cortex (lesionectomy) and multiple subpial tran- with medically refractory epilepsy, their disability can sections, which sever intracortical connections in a way be completely eliminated by surgical intervention. Only that prevents the spread of epilepsy and still preserves a small percentage of potential surgical candidates, how- the columnar structure necessary to maintain
    [Show full text]
  • Curriculum Vitae
    Lacritz CV CURRICULUM VITAE Laura H. Lacritz, Ph.D., ABPP/ABCN Address: University of Texas Southwestern Medical Center at Dallas Neuropsychology Department of Psychiatry 5323 Harry Hines Blvd. Dallas, TX 75390-8846 Telephone: Office: (214) 648-4650 Fax: (214) 648-4660 Email: [email protected] Date of Birth: April 24, 1967 Education: 1989 B.A. in Psychology (Phi Beta Kappa) The University Of Texas, Austin 1994 Ph.D. in Clinical Psychology The University Of Texas Southwestern Medical Center at Dallas School of Biomedical Sciences 1995 to Postdoctoral Fellowship in Clinical Neuropsychology 1997 The University Of Texas Southwestern Medical Center at Dallas Licensure: State of Texas Psychologist License # 25366 Board Certification: Diplomate in Clinical Neuropsychology American Board of Professional Psychology, Diploma #5557 Professional Experience: 9-2012 to Professor of Psychiatry, and Neurology and Neurotherapeutics Present The University of Texas Southwestern Medical Center at Dallas 10-2010 to Associate Professor of Neurology and Neurotherapeutics 8-2012 The University of Texas Southwestern Medical Center at Dallas 9-2005 to Associate Professor of Psychiatry 8-2012 The University of Texas Southwestern Medical Center at Dallas 1 Lacritz CV 10-97 to Assistant Professor of Psychiatry 8-2005 The University of Texas Southwestern Medical Center at Dallas 2-01 to Associate Director of Neuropsychology present The University of Texas Southwestern Medical Center at Dallas 6-99 to Graduate Faculty present Southwestern Graduate School of Biomedical Sciences 10-97 to Principal Neuropsychologist, Alzheimer’s Disease Center present UT Southwestern Medical Center at Dallas 7-95 to Post-doctoral fellowship in neuropsychology 10-97 UT Southwestern Medical Center Supervisor: C.
    [Show full text]
  • Magnetoencephalography/Magnetic Source Imaging
    Name of Blue Advantage Policy: Magnetoencephalography/Magnetic Source Imaging Policy #: 338 Latest Review Date: November 2020 Category: Radiology Policy Grade: B BACKGROUND: Blue Advantage medical policy does not conflict with Local Coverage Determinations (LCDs), Local Medical Review Policies (LMRPs) or National Coverage Determinations (NCDs) or with coverage provisions in Medicare manuals, instructions or operational policy letters. In order to be covered by Blue Advantage the service shall be reasonable and necessary under Title XVIII of the Social Security Act, Section 1862(a)(1)(A). The service is considered reasonable and necessary if it is determined that the service is: 1. Safe and effective; 2. Not experimental or investigational*; 3. Appropriate, including duration and frequency that is considered appropriate for the service, in terms of whether it is: • Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member; • Furnished in a setting appropriate to the patient’s medical needs and condition; • Ordered and furnished by qualified personnel; • One that meets, but does not exceed, the patient’s medical need; and • At least as beneficial as an existing and available medically appropriate alternative. *Routine costs of qualifying clinical trial services with dates of service on or after September 19, 2000 which meet the requirements of the Clinical Trials NCD are considered reasonable and necessary by Medicare. Providers should bill Original Medicare for covered services that are related to clinical trials that meet Medicare requirements (Refer to Medicare National Coverage Determinations Manual, Chapter 1, Section 310 and Medicare Claims Processing Manual Chapter 32, Sections 69.0-69.11).
    [Show full text]
  • Reversal of Cerebraldominance Forlanguage
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.49.6.628 on 1 June 1986. Downloaded from Journal of Neurology, Neurosurgery, and Psychiatry 1986;49:628-634 Reversal of cerebral dominance for language and emotion in a corpus callosotomy patient R JOSEPH From the W. Haven V. A. Medical Center, CT UHS/The Chicago Medical School, Chicago, USA SUMMARY A case study of a right-handed individual with epilepsy and brain dysfunction of early onset is described who was found, following callosotomy (sparing the rostrum of the callosum) to be left hemisphere "dominant" for processing and/or expressing emotional and somesthetic information, and right hemisphere "dominant" in regard to the expression and comprehension of language and linguistic stimuli. Hence, a significant reversal in functional representation, due presumably to an injury suffered early in life, was observed. Moreover, following callosotomy the patient demonstrated severe disconnection syndromes in regard to right hand usage, the recognition of emotion, and the production and comprehension of linguistically related information. The left cerebrum appeared to be almost completely without linguistic representation except in regard to emotional language. The possible mechanisms involved in functional sparing and reversed repre- sentation are briefly discussed, and the effects of partial disconnection on the expression of these capacities is presented. Protected by copyright. Approximately 89% of the population are genotypic motor) and also comes hierarchically to represent
    [Show full text]
  • 107. Impact of Posteroventral Pallidotomy Versus Chronic Pallidal Stimulation on Mood, Cognition and Quality of Life in Parkinson's Disease Ahmed Abdelrahman
    107. Impact of Posteroventral Pallidotomy Versus Chronic Pallidal Stimulation on Mood, Cognition and Quality of Life in Parkinson's Disease Ahmed AbdelRahman 101. Seizure Outcome Following Transcortical Selective Amygdalohippocampectomy In Mesial Temporal Lobe Epilepsy Feridun Acar 120. Complex Locking of Neuronal Activity During DBS in Human Patients Filippo Agnesi 122. Localization Of The Right Insular Cortex Cardioinhibitory Centre Faisal AlOtaibi 186. Stereotactic Thermocoagulation For Hypothalamic Hamartoma With Refractory Epilepsy Faisal AlOtaibi 75. Subgenual Cingulate and Anterior Capsule Stimulation as Treatment for Medically Refractory Body Dysmorphic Disorder Douglas Anderson 188. Deep Brain Stimulation (DBS) for the Tardive Dyskinesia Gabriel Arango 155. Degree of Cortical Atrophy affects Neuropsychological Outcome Following Bilateral Subthalamic (STN) Deep Brain Stimulation (DBS) in Patients with Parkinson Disease (PD). Hooman Azmi 156. Neuroimaging Variables Predict Post-operative Neuropsychological Performance In Patients With Parkinson Disease (PD) Following Placement Of Bilateral Deep Brain Stimulating (DBS) Electrodes In The Subthalamic Nucleus (STN) Hooman Azmi 40. Diffusion Tensor Imaging in Movement Disorder Surgery Garni Barkhoudarian 60. Subcutaneous Heparin For Prophylaxis Of Deep Venous Thrombosis In Deep Brain Stimulation Surgery Joel Bauman 118. Risk Factors for Hemorrhage During Microelectrode-Guided DBS and the Introduction of a Novel Microelectrode Design Sharona Ben-Haim 135. Surgical Treatment of Parietal Lobe Epilepsy Devin Binder 14. Development of Wireless Instantaneous Neurotransmitter Concentration Sensor (WINCS) for Intra-operative Neurochemical Monitoring during DBS surgery Jonathan Bledsoe 126. Stereotactic Neurosurgical Navigation using Ultra-High Field 7.0T MRI and HRRT PET Brain Imaging Zang He Cho 167. Coupled Control of Pain and Cerebral Blood Flow in the Medulla Justin Cetas 150.
    [Show full text]
  • Magnetoencephalography Magnetic Source Imaging
    Corporate Medical Policy Magnetoencephalography/Magnetic Source Imaging File Name: magnetoencephalography_magnetic_source_imaging Origination: 3/2002 Last CAP Review: 5/2020 Next CAP Review: 5/2021 Last Review: 5/2020 Description of Procedure or Service Magnetoencephalography (MEG) is a noninvasive functional imaging technique that records weak magnetic forces. When this information is superimposed on an anatomic image of the brain, typically a magnetic resonance imaging (MRI) scan the image is referred to as magnetic source imaging (MSI). MSI has been used to localize epileptic foci and to identify “eloquent” areas of the brain for neurosurgical planning. The primary advantage of MSI is that, while conductivity and thus measurement of electrical activity as recorded by electroencephalogram is altered by the surrounding brain structures, magnetic fields are not. Therefore, MSI permits a high-resolution image. Detection of weak magnetic fields requires gradiometer detection coils coupled to a superconducting quantum interference device, which requires a specialized room shielded from other magnetic sources. Mathematical modeling programs based on idealized assumptions are then used to translate detected signals into functional images. In its early evolution, clinical applications were limited by the use of only 1 detection coil requiring lengthy imaging times, which, because of body movement, also were difficult to match with the MRI. However, more recently, the technique has evolved to multiple detection coils in an array that can provide data more efficiently over a wide extracranial region. One clinical application is localization of the pre- and postcentral gyri as a guide to surgical planning in patients scheduled to undergo neurosurgery for epilepsy, brain neoplasms, arteriovenous malformations, or other brain disorders.
    [Show full text]
  • Wada Testing About the Test a Wada Test Examines Each Side of the Brain (Separately) To: ■ Find the Area That Controls Your Speech
    Northwestern Memorial Hospital Patient Education TESTS AND PROCEDURES Wada Testing About the Test A Wada test examines each side of the brain (separately) to: ■ Find the area that controls your speech. If you have ■ See which of the two temporal lobes has the better memory function. any questions, The exam is done before epilepsy surgery. The test results often help to: please ask your ■ Decide if surgery is an option for you. doctor or nurse. ■ Plan the surgery so that problems with speech and memory can be avoided. The Wada test takes about 4 hours. It is done in the Interventional Radiology (IR) department and includes an: ■ EEG (electroencephalogram) with real-time video recording. It looks at the electrical activity of the brain and the body’s response during the test. ■ Angiogram X-ray test that uses dye (or “contrast”) to show the blood vessels of the head. It also allows for placement of the catheter used during the Wada test. An overnight hospital stay is not needed. Before the Test Do not eat or drink after midnight the day before your test. Needed medicines may be taken with sips of water. Day of the Test Plan to arrive 15 minutes before your test time. Be sure to bring: ■ Photo ID. ■ Insurance card. ■ Medicare card (for Medicare patients). ■ List of allergies and current medicines. ■ Toiletries and other personal items. Please leave all valuables (jewelry, credit cards, money) at home. Arrival Please come to the 4th Floor Reception Desk in the Feinberg Pavilion, 251 East Huron Street. Parking is available for patients and visitors in the garage at 222 East Huron Street, across from the Feinberg and Galter pavilions.
    [Show full text]